The gap analysis is based upon conclusions drawn by surveying APEC economies. The responding economies provided information on existing strategies and best practices for economic incentives for antimicrobials relevant to APEC economies. This included examining and addressing barriers to market entry for new drugs and diagnostics. The gap analysis includes responses to the survey and graphical depiction of how the responding economies replied.